We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An industry group has updated its pharmaceutical supply chain management guideline, implementing the latest changes in data standards ahead of federal standards mandating the ability to track and trace individual drug products. Read More
GlaxoSmithKline has filed an amicus brief in support of Bristol-Myers Squibb’s U.S. Supreme Court petition, which asks for a review of the California high court’s decision allowing plaintiffs outside the state to sue the drugmaker in the state’s court system. Read More
Mylan declined to voluntarily testify before a Senate committee on its settlement with the Justice Department over its misclassification of the EpiPen for a Medicaid drug rebate program. Read More
Pfizer is suing a Texas health agency for disclosing pricing and rebate information to state lawmakers, alleging the release violates state and federal laws on confidential data. Read More
Pharmaceutical representatives in Chicago must complete a professional education course and be licensed before conducting business, following the unanimous passage of a new ordinance by the city council as part of its plan to combat the opioid epidemic. Read More
A federal judge ruled that a generic version of Merck’s Nasonex developed by Teva Pharmaceuticals does not infringe patent claims covering the allergy treatment’s active ingredient. Read More